Sanofi dengue vaccine promising but questions remain
Thursday, July 10, 2014 - 19:00
in Health & Medicine
PARIS (Reuters) - The first vaccine against dengue fever, from France's Sanofi, provided moderate protection in a large clinical study, but questions remain as to how well it can help fight the world's fastest-growing tropical disease.